Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Chazboy. Great post. I mentioned this company to a friend of mine earlier today and he appeared very enthusiastic at looking at the fundermentals of this company.
Arb
Bought some more today. Holding for 12/18 months . I like the fact the company is doing things and achieving great results.
Probably best for your sanity to not look at the sp for a year... lol
I know I know.
I just like you to remind me old chap.
Bradley
They are competition, however look who we are in bed with....
This is a multi multi billion $ market, we are bound to get competition.
Hey I drive a Nissan, the chances are you don’t?
OB
Ok yes I get that. Just felt it reads like a competition company. You know what I mean.
It shows the demand for this type of technology, plus it always pays to know what’s going on in the field....
Please explain how that will benifit dmtr.
https://news.sky.com/story/fund-management-giant-blackrock-backs-100m-injection-into-uk-drug-developer-exscientia-12234979?dcmp=snt-sf-twitter
backs $100m injection into UK drug developer Exscientia
The world's biggest asset manager is taking a stake in a fast-growing Oxford-based AI drug develop, Sky News learns. Sky News has learnt that BlackRock is injecting a substantial sum into Oxford-based Exscientia in an updated Series C funding round that will be confirmed on Thursday.
The new capital, and the identity of its new investor, will provide a significant boost to one of Britain's fastest-growing pharmatech companies. It uses an end-to-end AI-first drug discovery platform called CentaurAI to discover new drugs significantly more quickly than industry benchmarks, and says it has created the first fully AI-designed drug to enter clinical trials and advance multiple drug candidates into pre-clinical testing. Exscientia has struck partnerships with Bristol-Myers Squibb, Sanofi and Bayer, as well as a number of biotech companies.